Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chongqing Zhifei Biological Products
Pharma
Sanofi, GSK and China reimbursement updates—Fierce Pharma Asia
Sanofi revealed a plan for a $1 billion manufacturing site in Beijing. GSK inked another ADC deal and revised its Shingrix pact with Zhifei. And more.
Angus Liu
Dec 6, 2024 9:00am
GSK cuts Shingrix deliveries in revised Zhifei China pact
Dec 5, 2024 10:52am
GSK partners up with Zhifei to market Shingrix in China
Oct 9, 2023 11:20am
The top 10 vaccine companies worldwide
Oct 17, 2022 3:00am
Merck quadruples Gardasil supply in China contract
Nov 12, 2018 10:38am
China’s latest vaccine scandal sparks fury and fear
Jul 23, 2018 11:14am